Review: Trials of injectable pneumococcal vaccines do not show effectiveness in chronic obstructive pulmonary disease

March 2007
ACP Journal Club;Mar/Apr2007, Vol. 146 Issue 2, p36
Academic Journal
The article cites a research study focusing on the role of injectable vaccines in the prevention of pneumococcal infection in patients with chronic obstructive pulmonary disease (COPD). Randomized controlled trials of patients suffering from COPD were conducted. The researchers reached to the conclusion that in patients with COPD, trials of injectable pneumococcal vaccines do not show effectiveness.


Related Articles

  • A management strategy that controls lower airway eosinophilic inflammation and symptoms reduced exacerbations in asthma. Green, R. H.; Brightling, C. E.; McKenna, S.; Pavord, I. D. // Evidence Based Medicine;Jul2003, p113 

    The article presents a study that compares the effectiveness of standard care and management strategy in reducing lower airway eosinophilic symptoms and inflammation of asthma exacerbations of patients in Leicester, England. Researchers did a blinded randomized controlled trials of the 74...

  • Tackling chronic obstructive pulmonary disease in Guangdong, China.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/4/2010, Vol. 341 Issue 7784, p1202 

    The article focuses on a randomized controlled trial conducted to both prevent and treat chronic obstructive pulmonary disease (COPD) in middle aged and older people in Guangzhou City, Guangdong, China.

  • Value of supplemental interventions to enhance the effectiveness of physical exercise during respiratory rehabilitation in COPD patients. A Systematic Review. Puhan, Milo A.; Sch√ľnemann, Holger J.; Frey, Martin; Bachmann, Lucas M. // Respiratory Research;2004, Vol. 5, p25 

    Background: There is a controversy about the additional benefit of various supplemental interventions used in clinical practice to further enhance the effectiveness of respiratory rehabilitation in patients with Chronic obstructive pulmonary disease (COPD). The aim of this research was to...

  • Pneumococcal Immunization: From Policy to Practice. Schwartz, Benjamin; Breiman, Robert F. // JAMA: Journal of the American Medical Association;9/5/90, Vol. 264 Issue 9, p1154 

    Editorial. Deals with the low utilization of pneumococcal vaccines targeted for adults in the U.S. Factors behind the lack of use of pneumococcal vaccines; Strategies that can be adopted to increase utilization of pneumococcal vaccines; Cost benefits of immunization.

  • Part A. Manufacturing recommendations.  // WHO Technical Report Series;2004, Issue 927, p70 

    The article provides information about pneumococcal conjugate vaccine. The descriptive definition of the vaccine and the international reference materials used are cited. It has been said that the serotypes included in the vaccine should be associated with the name of the vaccine and listed in...

  • PNEUMOCOCCAL AND INFLUENZA VACCINATION: CURRENT SITUATION AND FUTURE PROSPECTS. Horwood, F.; Macfarlane, J. // Thorax;Oct2002 Supplement 2, Vol. 57, pii24 

    Background:: The effectiveness of influenza and pneumococcal vaccination in the prevention of hospital admissions and death has not been assessed prospectively We have therefore examined the effects of influenza and pneumococcal vaccination in individuals aged 65 years or older in a 3-year...

  • Infants too young to receive pneumococcal conjugate vaccine benefit from herd immunity. Carter, R. J. F. // Thorax;Jul2006, Vol. 61 Issue 7, p610 

    The article reports that infants too young to receive a heptavalent pneumococcal conjugate vaccine (PCV7) are benefiting from herd immunity. Evidence has shown that the rate of invasive pneumococcal disease (IPD) among children younger than 2 years has reduced since the introduction of PCV7....

  • Conjugate Pneumococcal Vaccine in HIV-Infected Ugandans and the Effect of Past Receipt of Polysaccharide Vaccine. Miiro, George; Kayhty, Helena; Watera, Christine; Tolmie, Helen; Whitworth, James A. G.; Gilks, Charles F.; French, Neil // Journal of Infectious Diseases;11/15/2005, Vol. 192 Issue 10, p1801 

    We investigated the immunogenicity of a 7-valent conjugate pneumococcal vaccine (CPV) in human immuno deficiency virus-infected Ugandan adults and measured the effect of past pneumococcal polysaccharide vaccine (PPV) receipt given as part of a controlled trial. Two doses of CPV, 4 weeks apart,...

  • Does pneumococcal conjugate vaccine prevent otitis media? Reilly, Philip; Jankowski, Terry Ann // Journal of Family Practice;Aug2011, Vol. 60 Issue 8, p488 

    The article offers information on the effectiveness of pneumococcal conjugate vaccine (PCV) to prevent otitis media. It states that PCV before 12 months of age reduces the incidence of acute otitis media (AOM) and recurrent otitis media (ROM). It says that PCV also minimizes tympanostomy tube...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics